Phase 3 PAP Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Who Are on Positive Airway Pressure Ventilation (PAP) Therapy
Subjects With Moderate-to-severe OSA and Obesity Who Are on PAP Therapy
Fujian Shengdi Pharmaceutical Co., Ltd.140 enrolled1 locationNCT06994650
Recruiting
Phase 3
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)
Human Papilloma Virus (HPV)WartsCommon Warts+1 more
Verrica Pharmaceuticals Inc.300 enrolled6 locationsNCT07246590
Recruiting
Phase 2Phase 3
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
MelanomaOvarian NeoplasmsColorectal Neoplasms+3 more
Cancer Research UK30 enrolled16 locationsNCT05768178
Recruiting
Phase 3
Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer
Head and Neck CancerOropharynx CancerHuman Papilloma Virus
Centre hospitalier de l'Université de Montréal (CHUM)360 enrolled2 locationsNCT04178174
Recruiting
Phase 3
A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer.
Papillary Thyroid Cancer
Second Affiliated Hospital of Xi'an Jiaotong University400 enrolled1 locationNCT06791005